Franczyk, B.; Lisińska, W.; Hossa, K.; Katańska, K.; Wieczorek, A.; Prusak, A.; Biegała, Z.; Rysz, J.; Młynarska, E.
Resolving Inflammation in CKD: The Potential of SPMs and Omega-3 Derivatives as Biomarkers and Therapeutics. Biomedicines 2026, 14, 619.
https://doi.org/10.3390/biomedicines14030619
AMA Style
Franczyk B, Lisińska W, Hossa K, Katańska K, Wieczorek A, Prusak A, Biegała Z, Rysz J, Młynarska E.
Resolving Inflammation in CKD: The Potential of SPMs and Omega-3 Derivatives as Biomarkers and Therapeutics. Biomedicines. 2026; 14(3):619.
https://doi.org/10.3390/biomedicines14030619
Chicago/Turabian Style
Franczyk, Beata, Wiktoria Lisińska, Katarzyna Hossa, Kinga Katańska, Anna Wieczorek, Aleksandra Prusak, Zuzanna Biegała, Jacek Rysz, and Ewelina Młynarska.
2026. "Resolving Inflammation in CKD: The Potential of SPMs and Omega-3 Derivatives as Biomarkers and Therapeutics" Biomedicines 14, no. 3: 619.
https://doi.org/10.3390/biomedicines14030619
APA Style
Franczyk, B., Lisińska, W., Hossa, K., Katańska, K., Wieczorek, A., Prusak, A., Biegała, Z., Rysz, J., & Młynarska, E.
(2026). Resolving Inflammation in CKD: The Potential of SPMs and Omega-3 Derivatives as Biomarkers and Therapeutics. Biomedicines, 14(3), 619.
https://doi.org/10.3390/biomedicines14030619